This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Spectranetics Broadens Laser Catheter Portfolio To Treat Complex Lesions And Chronic Total Occlusions (CTOs)

COLORADO SPRINGS, Colo., Aug. 19, 2013 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced the launch of the Turbo Elite ® .035 product line extension. The two new catheter sizes – with diameters of 2.3 mm and 2.5 mm – are compatible with a .035" guidewire, augmenting the versatility of the Turbo Elite laser to treat complex lesions including chronic total occlusions (CTOs) in blood vessels above and below the knee.

The Turbo Elite laser atherectomy catheter was designed specifically for the treatment of Peripheral Artery Disease (PAD), vaporizing blockages in leg vessels and restoring blood flow. The minimally invasive procedure requires less recovery time than bypass surgery and often provides patients with an alternative to amputation.

Vascular surgeon Lawrence J. Goldstein, MD, FACS, participated in clinical evaluations which were conducted at selected regional sites in the U.S. and Europe. He reports consistently saving time and resources when performing crossing procedures with the Turbo Elite system. According to Dr. Goldstein, "I typically attempt to cross an occlusion by first using a .035 guidewire. Because these new catheter sizes are compatible with this wire size, they eliminate the need to change wires to perform the laser atherectomy procedure once I have crossed the lesion."

According to Donna Ford-Serbu, Senior Vice President Global Marketing, Strategy and Portfolio, the Turbo Elite .035 system enables clinicians to cross what is often considered an 'uncrossable' lesion without using a wire. These lesion types are frequently encountered in complex chronic total occlusions, which are reported in up to 40% of patients with peripheral lesions caused by PAD, leaving interventionalists with few treatment options.

"Using a step-by-step lasing technique*, the Turbo Elite .035 can be used to cross a CTO without a guidewire," said Ms. Ford-Serbu. "These new catheters will help fill a need expressed by many interventionalists: more CTO crossing tools. They now have a broader range of versatility that offers safe, proven solutions for patients."

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,678.23 -40.31 -0.23%
S&P 500 2,056.15 -4.90 -0.24%
NASDAQ 4,863.3620 -13.1570 -0.27%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs